Compugen Ltd.
(TEL Aviv Stock Exchange : CGEN)

( )
CGEN After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
AMGNAmgen, Inc. -0.07%285.571.5%$807.21m
GILDGilead Sciences, Inc. 1.91%89.471.0%$684.83m
MRNAModerna, Inc. 3.18%184.700.0%$672.59m
REGNRegeneron Pharmaceuticals, Inc. 0.15%765.422.6%$496.31m
VRTXVertex Pharmaceuticals, Inc. 1.18%321.321.9%$475.30m
BIIBBiogen, Inc. -1.04%289.101.8%$406.54m
ILMNIllumina, Inc. 0.91%210.423.2%$228.85m
BNTXBioNTech SE 5.65%171.810.0%$161.35m
BMRNBioMarin Pharmaceutical, Inc. 0.68%104.394.2%$159.57m
RXDXPrometheus Biosciences, Inc 22.35%117.211.4%$149.18m
AXSMAxsome Therapeutics, Inc. -0.40%77.851.6%$142.46m
SNSSSunesis Pharmaceuticals, Inc. -6.74%1.800.7%$125.83m
MRTXMirati Therapeutics, Inc. -11.58%43.851.6%$98.02m
NVAXNovavax, Inc. 0.58%17.3275.3%$81.87m
HALOHalozyme Therapeutics, Inc. 0.19%57.8518.4%$81.73m

Company Profile

Compugen Ltd. engages in the research, development, and commercialization of therapeutic and diagnostic biomarker product candidates including proteins and monoclonal antibodies. It focuses on research and development on immuno-oncology and autoimmune diseases. The company was founded by Eli Mintz, Simchon Faigler, and Amir Natan on February 10, 1993 and is headquartered in Holon, Israel.